Back
Medtronic Plc 10K Form
Buy
63
MDT
Medtronic Plc
Last Price:
$102.00
Seasonality Move:
2.61%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-06-20 | 10K | MDT/Medtronic Plc Annual |
| 2024-02-27 | 10Q | MDT/Medtronic Plc Quarterly |
| 2023-11-30 | 10Q | MDT/Medtronic Plc Quarterly |
| 2023-08-31 | 10Q | MDT/Medtronic Plc Quarterly |
| 2023-06-22 | 10K | MDT/Medtronic Plc Annual |
| 2023-03-01 | 10Q | MDT/Medtronic Plc Quarterly |
Receive MDT News And Ratings
See the #1 stock for the next 7 days that we like better than MDT
MDT Financial Statistics
Sales & Book Value
| Annual Sales: | $33.5B |
|---|---|
| Cash Flow: | $457M |
| Price / Cash Flow: | 25.21 |
| Annual Sales: | $37.95 |
| Price / Book: | 2.69 |
Profitability
| EPS (TTM): | 3.70170 |
|---|---|
| Net Income (TTM): | $4.8B |
| Gross Margin: | $20.1B |
| Return on Equity: | 9.84% |
| Return on Assets: | 5.28% |
Medtronic Plc Earnings Forecast
Key Medtronic Plc Financial Ratios
-
The Gross Profit Margin over the past 46 years for MDT is 59.78%.
-
The Selling, General & Administrative Expenses for MDT have been equal to 32.35% of Gross Profit Margin.
-
The Research & Development expenses have been 8.15% of Revenue.
-
The Interest Expense is 15.54% of Operating Income.
-
The Net Earning history of MDT is 13.99% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 28 years.
Medtronic Plc Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | MDT |
| CUSIP: | G5960L |
| Website: | medtronic.com |
Debt
| Debt-to-Equity Ratio: | 0.6 |
|---|---|
| Current Ratio: | 2.42 |
| Quick Ratio: | 1.5 |
Price-to-Earnings
| Trailing P/E Ratio: | 28.21 |
|---|---|
| Forward P/E Ratio: | 16.68 |
MDT Technical Analysis vs Fundamental Analysis
Buy
63
Medtronic Plc (MDT)
is a Buy
Is Medtronic Plc a Buy or a Sell?
-
Medtronic Plc stock is rated a BuyThe current Medtronic Plc [MDT] share price is $101.97. The Score for MDT is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.